Page last updated: 2024-12-11

ophthalmic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

ophthalmic acid: glutathione analog in which cysteine moiety is replaced by L-aminobutyrate [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

ophthalmic acid : A L-glutamine derivative that is L-glutamine substituted by a 1-[(carboxymethyl)amino]-1-oxobutan-2-yl at the terminal amino nitrogen atom. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID7018721
CHEBI ID84058
SCHEMBL ID15473350
MeSH IDM0066768

Synonyms (25)

Synonym
AKOS015841983
ophthalmic acid
495-27-2
unii-3a60475q1q
l-gamma-glutamyl-l-alpha-aminobutyrylglycine
3a60475q1q ,
gamma-glutamyl-alpha-amino-n-butyrylglycine
gamma-glu-alpha-aminobutyryl-gly
CHEBI:84058
l-.gamma.-glutamyl-l-.alpha.-aminobutyrylglycine
h-gamma-glu-abu-gly-oh
gamma-l-glutamyl-l-2-aminobutyrylglycine
C21016
SCHEMBL15473350
(2s)-2-amino-4-{[(1s)-1-[(carboxymethyl)carbamoyl]propyl]carbamoyl}butanoic acid
ophthalmic acid, >=97.0% (hplc)
ophthalmic acid (h-l-gglu-l-abu-gly-oh)
mfcd00076874
DTXSID40895053
n5-((s)-1-((carboxymethyl)amino)-1-oxobutan-2-yl)-l-glutamine
(s)-2-amino-5-((s)-1-(carboxymethylamino)-1-oxobutan-2-ylamino)-5-oxopentanoic acid
Q7098084
(s)-3-amino-3-(2-nitro-phenyl)-propionicacid
ophthalmicacid
(2s)-2-amino-5-[[(2s)-1-(carboxymethylamino)-1-oxobutan-2-yl]amino]-5-oxopentanoic acid

Research Excerpts

Overview

Ophthalmic acid (OA) is an analogue of GSH in which cysteine is replaced with 2-aminobutyrate.

ExcerptReferenceRelevance
"Ophthalmic acid (OA) is an analogue of GSH in which cysteine is replaced with 2-aminobutyrate."( Detection of Ophthalmic Acid in Serum from Acetaminophen-Induced Acute Liver Failure Patients Is More Frequent in Non-Survivors.
Karvellas, CJ; Kaur, G; Lee, WM; Leslie, EM; Swanlund, DP; Tillman, H, 2015
)
1.51

Dosage Studied

ExcerptRelevanceReference
" One of these is the increase in 5-oxoproline and ophthalmic acid concentrations with increased dosage of paracetamol."( A mathematical modelling approach to assessing the reliability of biomarkers of glutathione metabolism.
du Preez, FB; Geenen, S; Kenna, JG; Nijhout, HF; Reed, M; Snoep, JL; Westerhoff, HV; Wilson, ID, 2012
)
0.63
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
biomarkerA substance used as an indicator of a biological state.
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
L-glutamine derivativeA proteinogenic amino acid derivative resulting from reaction of L-glutamine at the amino group, the carboxy group, or the carboxamide, or from the replacement of any hydrogen of L-glutamine by a heteroatom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (3)

PathwayProteinsCompounds
ophthalmate biosynthesis010
Trans-sulfuration, one-carbon metabolism and related pathways053
One-carbon metabolism and related pathways038

Research

Studies (32)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (28.13)18.7374
1990's2 (6.25)18.2507
2000's4 (12.50)29.6817
2010's17 (53.13)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 28.77

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index28.77 (24.57)
Research Supply Index3.53 (2.92)
Research Growth Index4.97 (4.65)
Search Engine Demand Index44.62 (26.88)
Search Engine Supply Index2.80 (0.95)

This Compound (28.77)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (3.13%)5.53%
Reviews1 (3.13%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other30 (93.75%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]